Description
Eribulin Mesylate
Eribulin was approved for medical use in the European Union in March 2011, and it is indicated for the treatment of:
- people with locally advanced or metastatic breast cancer who have progressed after at least one chemotherapeutic regimens for advanced disease. Prior therapy should have included an anthracycline and a taxane unless the people were not suitable for these treatments.
- adults with unresectable liposarcoma who have received prior anthracycline containing therapy (unless unsuitable) for advanced or metastatic disease.
List of Generic Brands for Eribulin Mesylate In India
Embremma (Eribulin Mesylate), Halaven (Eribulin Mesylate), Mitobulin (Eribulin Mesylate), Teceris (Eribulin Mesylate)
Eribulin Mesylate – Global Pharmaceutical Supplier & Distributor
Aark Pharmaceuticals, a globally trusted and licensed pharmaceutical stockist, wholesaler, distributor, and exporter based in India, has established a strong presence across multiple countries through an extensive network of distribution centers and partner pharmacies. The company supplies and distributes pharmaceutical products to leading distributors, wholesalers, hospitals, and clinics in the South America, and North America regions, Europe, Middle East, Asia-Pacific, Africa, and other international markets.
Aark offers high-quality generic medicines, including several brands of Eribulin Mesylate, all manufactured in Indian manufacturer to meet global standards. If you are looking generic brands for Eribulin Mesylate Injection in India. Please contact us at +91 9953466646 or WhatsApp at 9953466646 or email us at sales@aarkpharma.com. Our representatives will be happy to assist you and answer any questions you may have Glycopyrrolate Tablets Price is available at Aark Pharmaceuticals.
